Evidence map›Paper›PMID 38620211›Full record

ArticleEnfermedades infecciosas y microbiologia clinica2005

Current situation in the development of a preventive HIV vaccine.

José Alcamí, Joan Joseph Munné, María Ángeles Muñoz-Fernández, Mariano Esteban

Abstract read
In one paragraph

Article in Enfermedades infecciosas y microbiologia clinica, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

José AlcamíUnidad de Inmunopatología del Sida. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Majadahonda. España.
Joan Joseph MunnéEstudio y Desarrollo de Vacunas frente al VIH. Unidad Estudio del Sida. Hospital Clínic. Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS). Facultad de Medicina. Universidad de Barcelona. Hospital Clínic. Barcelona. España.
María Ángeles Muñoz-FernándezLaboratorio Inmunobiología Molecular. Hospital General Universitario Gregorio Marañón. Madrid. España.
Mariano EstebanCentro Nacional de Biotecnología. Consejo Superior de Investigaciones Científicas (CSIC). Campus Universidad Autónoma. Madrid. Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The uncontrolled progression of the aids epidemic has made the development of an efficacious human immunodeficiency virus (HIV) vaccine a major objective of scientific research. No effective preventive vaccine against HIV is currently available and sterilizing immunity has not yet been achieved in animal models. This review analyses the major challenges in developing an aids vaccine, in particular the mechanisms involved in viral escape from the immune response, and summarizes the results obtained with the different prototypes of therapeutic and preventive vaccines. Finally, social, economic and healthcare aspects of research into HIV vaccines and current controversies regarding the development of clinical trials are discussed.

Indexed as

AidsAntiviral immunityHIVVaccineViral escape mechanisms

Identifiers

PMID38620211
PMCPMC7130212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.